# Nautilus (NCT06066437)

> NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

No report yet. It can be ordered.

- Drugs tested: 177Lu rhPSMA-10.1; 177Lu rhPSMA-10.1 plus degarelix
- Indication: prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06066437
- Phase: PHASE1, PHASE2
- Status: RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Prostate Cancer
- Interventions: Arm A: 177Lu rhPSMA-10.1; Arm B: 177Lu rhPSMA-10.1 plus Degarelix
- Enrollment: 6
- Primary outcome: Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
- Primary outcome: Efficacy will be assess by measuring the radiation dose to the tumor (dosimetries) and PSA assessment

## Some of the questions raised in the 15 indexed sources

_Automated from all 15 indexed sources (May 2023 – Jan 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice._

- Whether adding ADT to neoadjuvant Lu-177 PSMA is needed before surgery
- Whether and when ADT up-regulates PSMA expression enough to prime Lu-177 PSMA uptake
- Whether Lu-177 PSMA is better given before ADT, in hormone-naive high-risk localized disease
- Which tissue biomarkers from surgery can guide treatment after neoadjuvant Lu-177 PSMA

## Indexed commentary on Nautilus so far

Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 8 posts on X
- 5 YouTube videos
- 2 podcast episodes

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nautilus-nct06066437

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06066437", "email": "<work email>"}; the inbox owner confirms by the emailed link.
